Mitochondrial mass governs the extent of human T cell senescence.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 31788930.
- Also identified by DOI 10.1111/acel.13067 and PMC identifier 6996952.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The susceptibility of human CD4<sup>+</sup> and CD8<sup>+</sup> T cells to senesce differs, with CD8<sup>+</sup> T cells acquiring an immunosenescent phenotype faster than the CD4<sup>+</sup> T cell compartment. We show here that it is the inherent difference in mitochondrial content that drives this phenotype, with senescent human CD4<sup>+</sup> T cells displaying a higher mitochondrial mass. The loss of mitochondria in the senescent human CD8<sup>+</sup> T cells has knock-on consequences for nutrient usage, metabolism and function. Senescent CD4<sup>+</sup> T cells uptake more lipid and glucose than their CD8<sup>+</sup> counterparts, leading to a greater metabolic versatility engaging either an oxidative or a glycolytic metabolism. The enhanced metabolic advantage of senescent CD4<sup>+</sup> T cells allows for more proliferation and migration than observed in the senescent CD8<sup>+</sup> subset. Mitochondrial dysfunction has been linked to both cellular senescence and aging; however, it is still unclear whether mitochondria play a causal role in senescence. Our data show that reducing mitochondrial function in human CD4<sup>+</sup> T cells, through the addition of low-dose rotenone, causes the generation of a CD4<sup>+</sup> T cell with a CD8<sup>+</sup> -like phenotype. Therefore, we wish to propose that it is the inherent metabolic stability that governs the susceptibility to an immunosenescent phenotype.
Medical subject headings
- CD8-Positive T-Lymphocytes
- Cellular Senescence
- Immunosenescence
- Mitochondria